XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net loss $ (62,493,000) $ (77,702,000) $ (78,208,000)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 3,000,000 2,518,000 2,997,000
Amortization of investment discount 98,000 226,000 99,000
Equity-based compensation expense 10,625,000 22,047,000 16,464,000
Amortization of debt discount and issuance costs 474,000 11,542,000 11,168,000
Amortization of debt discount related party 834,000 0 0
Realized loss on available-for-sale securities 0 0 3,000
Unrealized loss on equity investments 211,000 0 0
Loss (gain) on disposal of property and equipment 133,000 (75,000) 785,000
Gain on extinguishment of debt (3,565,000) (9,793,000) 0
Inventory write-down 0 4,500,000 0
(Increase) decrease in assets:      
Contributions to deferred compensation plan (298,000) (484,000) (357,000)
Accounts receivable (96,000) (770,000) 1,592,000
Inventory (236,000) (415,000) (1,356,000)
Prepaid expense and other assets 138,000 1,014,000 (2,087,000)
Increase (decrease) in liabilities:      
Accounts payable 2,920,000 273,000 (1,006,000)
Accrued liabilities and other (861,000) (469,000) (909,000)
Accrued interest (437,000) (283,000) 0
Accrued interest from related-party 663,000 0 0
Deferred revenue and income 96,000 75,000 105,000
Deferred compensation 66,000 473,000 316,000
Net cash used in operating activities (48,728,000) (47,323,000) (50,394,000)
Cash flows from investing activities:      
Purchases of equipment (554,000) (603,000) (1,362,000)
Purchase of marketable securities (27,506,000) (30,081,000) (46,933,000)
Proceeds from sales of marketable securities 0 250,000 0
Maturities of marketable securities 40,477,000 38,738,000 61,901,000
Net cash provided by investing activities 12,417,000 8,304,000 13,606,000
Cash flows from financing activities:      
Proceeds from issuance of common and preferred shares, net 32,872,000 42,880,000 359,000
Proceeds from exercise of options 7,000 1,620,000 6,062,000
Proceeds from issuance of common stocks under employee purchase plan 224,000 326,000 0
Proceeds from debt 0 0 5,578,000
Payment of debt (80,000) (360,000) (366,000)
Payments on finance leases (1,201,000) 0 0
Debt exchange and common stock issuance cost (192,000) (1,240,000) 0
Net cash provided by financing activities 31,630,000 43,226,000 11,633,000
Effect of exchange rate on cash (312,000) (90,000) (78,000)
(Decrease) increase in cash and cash equivalents (4,993,000) 4,117,000 (25,233,000)
Cash and cash equivalents, beginning of period 39,898,000 35,781,000 61,014,000
Cash and cash equivalents, end of period 34,905,000 39,898,000 35,781,000
Non-cash investing activities:      
Net transfer of instruments from inventory to property and equipment, net 168,000 688,000 1,525,000
Non-cash financing activities:      
Extinguishment of convertible senior notes through issuance of common stock 10,180,000 38,902,000 0
Convertible notes due from related-party extinguished in connection with the exchange transaction, net of deferred issuance costs 49,624,000 0 0
Fair value of new note from related-party issued in connection with the exchange transaction 16,024,000 0 0
Fair value of common stock warrant issued to related-party in connection with exchange transaction 3,753,000 0 0
Capital contribution from related-party in connection with the exchange transaction 29,847,000 0 0
Right-of-use assets obtained in exchange for finance lease obligations 3,096,000 0 0
Supplemental cash flow information:      
Interest paid 2,214,000 4,288,000 4,288,000
Income taxes paid, net of refunds $ 0 $ 0 $ 43,000